Related Experiment Video
Updated: Jul 29, 2026

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens
Published on: February 4, 2014
Primary ovarian peripheral primitive neuroectodermal tumor presented with breast metastasis; Case report
Razan Rabi1, Majd Hamed Allah2, Yusuf Dawabsheh3
1Internal Medicine Department, An-Najah National University Hospital, Nablus, Palestine.
Metastatic extraskeletal Ewing sarcoma (ESFT) presents diagnostic challenges and poor outcomes. This case details a young woman with ovarian ESFT metastasizing to the breast, dura, spine, and bone, highlighting treatment complexities.
Area of Science:
- Oncology
- Pathology
- Medical Imaging
Background:
- Ewing sarcoma family tumors (ESFT) are rare and challenging to diagnose, particularly extraskeletal forms.
- Metastatic ESFTs are associated with poor prognoses despite therapeutic advancements.
Observation:
- A 21-year-old woman presented with a breast mass and abdominal distention, initially suspected as primary breast cancer.
- Biopsy revealed metastatic extraskeletal Ewing sarcoma in the breast, with the primary tumor identified as originating in the ovary.
- Imaging confirmed widespread metastasis, including to the dura, spine, and bone, with optic nerve involvement.
Findings:
- Histopathology and immunohistochemistry confirmed Ewing sarcoma, originating from the ovary and metastasizing to the breast.
- Initial chemotherapy (VDC/IE) achieved tumor cytoreduction, but disease progression occurred within two years.
- Subsequent treatment with radiotherapy and high-dose ifosfamide chemotherapy was ineffective, leading to patient demise.
Implications:
- This case highlights the diagnostic difficulties and aggressive nature of metastatic extraskeletal Ewing sarcoma.
- Effective treatment protocols for advanced ESFT remain elusive, necessitating further research.
- Improved management strategies are crucial for enhancing outcomes in patients with metastatic ESFT.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020